Navigation Links
NxStage Introduces Web-Based Dosing Calculator
Date:9/23/2013

LAWRENCE, Mass., Sept. 23, 2013 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced the immediate availability of the NxStage Dosing Calculator. Designed for use with the NxStage® System One™, this online tool helps physicians develop prescriptions tailored to patients' clinical and lifestyle objectives.

(Logo: http://photos.prnewswire.com/prnh/20110503/MM94799LOGO )

Home hemodialysis, particularly when delivered more frequently, is shown to significantly improve patients' quality-of-life and other important clinical outcomes. Because traditional in-center dialysis treatment schedules are constrained by staffing and time-slot availability, home therapy presents additional flexibility with which to address clinical and lifestyle needs. This readily accessible tool will help clinicians decide upon the course of care to achieve their objectives.

Using formulas from peer-reviewed publications, the Dosing Calculator quickly displays a wide range of therapy frequencies and durations to assist nephrologists in prescribing for a desired dose. This online tool is expected to significantly reduce nephrologist time in calculating and assessing hundreds of possible prescription options to achieve clinical goals.

"We are committed to increasing access to home hemodialysis therapy based upon its life-changing benefits to patients and their families, and ensuring a simple prescription process is important to this goal," said Jeffrey H. Burbank, Chief Executive Officer of NxStage Medical, Inc. "With this web-based tool, physicians now have a new way to target their clinical goals while giving patients maximum flexibility to live their lives as they wish."

The interactive online tool is available on the NxStage web site or can be accessed directly at http://dosingcalculator.nxstage.com. The Dosing Calculator is a free service for health care providers.

About the NxStage System One

The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage Pureflow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid on demand. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs, at home or on vacation. http://www.nxstage.com/.

About NxStage Medical

NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at www.nxstage.com.

Forward-Looking Statements

This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended June 30, 2013. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Kristen K. Sheppard, Esq.
VP, Investor Relations
ksheppard@nxstage.com


'/>"/>
SOURCE NxStage Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. NxStage Urges CMS to Fix Training Reimbursement to Provide Medicare Patients Greater Access to Life-Changing Home Hemodialysis Therapies
2. NxStage Reports Record Revenue For The Second Quarter Of Fiscal 2013
3. NxStage Congratulates Home Dialyzors United for Securing Policies through the US Department of Transportation to Improve the Air Travel Experience for Home Dialyzors
4. Jay Shreiner Joins NxStage Board of Directors
5. NxStage Announces New Agreements with DaVita
6. NxStage Announces Second Quarter 2013 Investor Conference Schedule
7. NxStage Reports First Quarter 2013 Financial Results
8. NxStage Announces FDA Clearance for New High Flow Capabilities with NxStage System One
9. NxStage Names Robert G. Funari Chairman Of The Board
10. NxStage Completes Move to Direct Sales In UK
11. NxStage Educational Reception at Annual Dialysis Conference Features Celebrity and Former NxStage User Stephen Furst
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... 2017 Medical information groups within the ... self-service capabilities to manage inquiries from external stakeholders ... New research from consulting leader Best Practices, LLC ... website portals where HCPs can sign on and ... many findings to emerge from the new study ...
(Date:2/24/2017)... -- Report analyzes the worldwide markets for Endodontic Supplies in ... US, Canada , Japan ... , Latin America , and Rest of ... 2015 through 2022. Also, a six-year historic analysis is provided ... primary and secondary research. Company profiles are primarily based on ...
(Date:2/24/2017)... -- Directors from Pharma To Market Pty Ltd and Ador Consulting Pte ... the founding of Pharma To Market Pte Ltd, based in ... to announce their expansion into Asia with ... The company are delighted to appoint Joelle Chia , former ... based entity. Joelle brings with her an extensive business ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim Jong-nam, ... nerve agents and the deadly use of chemical weapons. Many questions exist about the ... small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical Institute, ...
(Date:2/26/2017)... San Mateo, CA (PRWEB) , ... February 26, 2017 , ... ... Bay Area cities as diverse as Millbrae, Belmont, and Palo Alto, is proud to ... San Mateo. Many Bay Area consumers look for home care close to home, and ...
(Date:2/26/2017)... Overland Park, KS (PRWEB) , ... ... ... launch of StaffBridge sets a new technology standard in staffing, scheduling, and ... to manage, monitor, and predict activity throughout the entire staffing process. StaffBridge ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... (PD) in persons with a specific LRRK2 mutation, according to a study released ... studies have provided evidence of a link between pesticides and incidence of sporadic ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... tooth replacement options at his office, Antoine Dental Center. Currently, patients can get ... Some restrictions may apply, but patients can learn more about these offers by ...
Breaking Medicine News(10 mins):